Viewing Study NCT01035502


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-03-02 @ 4:24 PM
Study NCT ID: NCT01035502
Status: COMPLETED
Last Update Posted: 2013-09-27
First Post: 2009-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia
Sponsor:
Organization: